70 related articles for article (PubMed ID: 11474471)
1. The renal metabolism of insulin: urinary insulin excretion in patients with mutant insulin syndrome (insulin Wakayama).
Hanabusa T; Oki C; Nakano Y; Okai K; Nishi M; Sasaki H; Sanke T; Nanjo K
Metabolism; 2001 Aug; 50(8):863-7. PubMed ID: 11474471
[TBL] [Abstract][Full Text] [Related]
2. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
[TBL] [Abstract][Full Text] [Related]
3. The renal handling of insulin.
Chamberlain MJ; Stimmler L
J Clin Invest; 1967 Jun; 46(6):911-9. PubMed ID: 6026097
[TBL] [Abstract][Full Text] [Related]
4. Insulin resistance and low urinary citrate excretion in calcium stone formers.
Cupisti A; Meola M; D'Alessandro C; Bernabini G; Pasquali E; Carpi A; Barsotti G
Biomed Pharmacother; 2007 Jan; 61(1):86-90. PubMed ID: 17184967
[TBL] [Abstract][Full Text] [Related]
5. [Regulation of natriuresis in diabetic nephropathy].
Późniak J
Ann Acad Med Stetin; 2000; 46():241-52. PubMed ID: 11712308
[TBL] [Abstract][Full Text] [Related]
6. Structurally abnormal insulin in a diabetic patient. Characterization of the mutant insulin A3 (Val----Leu) isolated from the pancreas.
Sakura H; Iwamoto Y; Sakamoto Y; Kuzuya T; Hirata H
J Clin Invest; 1986 Dec; 78(6):1666-72. PubMed ID: 3537011
[TBL] [Abstract][Full Text] [Related]
7. Beta-cell function and mass in type 2 diabetes.
Larsen MO
Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971
[TBL] [Abstract][Full Text] [Related]
8. Mutant insulin syndromes.
Vinik A; Bell G
Horm Metab Res; 1988 Jan; 20(1):1-10. PubMed ID: 3286444
[TBL] [Abstract][Full Text] [Related]
9. Detection and analysis of urinary peptides by on-line liquid chromatography and mass spectrometry: application to patients with renal Fanconi syndrome.
Cutillas PR; Norden AG; Cramer R; Burlingame AL; Unwin RJ
Clin Sci (Lond); 2003 May; 104(5):483-90. PubMed ID: 12529166
[TBL] [Abstract][Full Text] [Related]
10. [Tuberculosis in compromised hosts].
Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
[TBL] [Abstract][Full Text] [Related]
11. Renal glucose excretion and tubular reabsorption rate related to blood glucose in subjects with type 2 diabetes with a critical reappraisal of the "renal glucose threshold" model.
Wolf S; Rave K; Heinemann L; Roggen K
Horm Metab Res; 2009 Aug; 41(8):600-4. PubMed ID: 19418417
[TBL] [Abstract][Full Text] [Related]
12. Diabetes-associated mutations in human insulin: crystal structure and photo-cross-linking studies of a-chain variant insulin Wakayama.
Wan ZL; Huang K; Xu B; Hu SQ; Wang S; Chu YC; Katsoyannis PG; Weiss MA
Biochemistry; 2005 Apr; 44(13):5000-16. PubMed ID: 15794638
[TBL] [Abstract][Full Text] [Related]
13. Lysosomal enzymuria is a feature of hereditary Fanconi syndrome and is related to elevated CI-mannose-6-P-receptor excretion.
Norden AG; Gardner SC; Van't Hoff W; Unwin RJ
Nephrol Dial Transplant; 2008 Sep; 23(9):2795-803. PubMed ID: 18174267
[TBL] [Abstract][Full Text] [Related]
14. [Effect of a modified low protein and low fat diet on histologic changes and metabolism in kidneys in an experimental model of polycystic kidney disease].
Banković-Calić N; Ogbori MR; Nicman E
Srp Arh Celok Lek; 2002; 130(7-8):251-7. PubMed ID: 12585002
[TBL] [Abstract][Full Text] [Related]
15. Renal sodium handling in patients with normal pressure glaucoma.
Pechere-Bertschi A; Sunaric-Megevand G; Haefliger I; Panarello F; Maillard M; Burnier M
Clin Sci (Lond); 2007 Jun; 112(6):337-44. PubMed ID: 17014421
[TBL] [Abstract][Full Text] [Related]
16. Tubular and glomerular function in children after renal transplantation.
Dagan A; Eisenstein B; Bar-Nathan N; Cleper R; Krause I; Smolkin V; Davidovits M
Pediatr Transplant; 2005 Aug; 9(4):440-4. PubMed ID: 16048594
[TBL] [Abstract][Full Text] [Related]
17. Urinary excretion of endothelin receptors ET A and ET B in hypertensive patients and normotensive subjects.
Karram T; Khamaisi M; Bishara B; Ramadan R; Nitecki S; Ben-Izhak O; Meretyk S; Winaver J; Heyman SN; Hoffman A; Abassi Z
Kidney Blood Press Res; 2009; 32(4):293-303. PubMed ID: 19797914
[TBL] [Abstract][Full Text] [Related]
18. Identification of human metabolites of (-)-N-{2-[(R)-3-(6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline-2-carbonyl)piperidino]ethyl}-4-fluorobenzamide (YM758), a novel If channel inhibitor, and investigation of the transporter-mediated renal and hepatic excretion of these metabolites.
Umehara K; Shirai N; Iwatsubo T; Noguchi K; Usui T; Kamimura H
Drug Metab Dispos; 2009 Aug; 37(8):1646-57. PubMed ID: 19439489
[TBL] [Abstract][Full Text] [Related]
19. The renal metabolism of pepsinogen A and C in man.
ten Kate RW; Pals G; Eriksson AW; Donker AJ; Meuwissen SG
Clin Nephrol; 1989 Feb; 31(2):103-6. PubMed ID: 2920466
[TBL] [Abstract][Full Text] [Related]
20. Toxicology and Carcinogenesis Studies of Ochratoxin A (CAS No. 303-47-9) in F344/N Rats (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1989 May; 358():1-142. PubMed ID: 12695783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
